VIRTUAL CONFERENCE
From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You’ll hear from experts at Deloitte, Ernst & Young, Effectus Group, life science analysts and your industry counterparts.
LEARNING OBJECTIVES:
- Understand the latest accounting changes in key areas
- Recognize the timelines and key factors affecting the life science industry
- Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost: $695
This event will run 8:45-4:55p (Pacific Time) each day.
Register any one of three ways:
1. Register online using a credit card and click the orange button
2. Register by phone at (610) 789-3110
3. Email your contact info to be invoiced to [email protected]
| Agenda: DAY 1 | ||
|---|---|---|
| 8:45 | 10:10 | SEC & FASB Developments Affecting Life Science Companies Disaggregation of income statement expenses Improvements to income tax disclosures SEC Comment Letter trends FASB developments US regulatory updates PCAOB standard-setting and rulemaking activity |
| 10:10 | 10:20 | Break |
| 10:20 | 11:50 | Gross to Net & Inventory Accounting Gross to Net Introduction and Overview Industry View Estimation Methodology Approaching Launch Key Challenges SEC Comments Close and Financial Reporting GTN Hot Topics Discussion Inventory Accounting Refresh |
| 11:50 | 12:00 | Lunch Break |
| 12:00 | 1:00 | Tax Update Legislative Update: Policy, Politics and Process Ramp up to mide-terms Voters like change Tax policy questions: looking ahead |
| 1:00 | 2:00 | Lunch Break |
| 2:00 | 2:50 | GenAI Automation Update What works and what doesn't in corporate accounting Understanding the AI spectrum and AI agents AI in financial reporting & demo Potential impacts to your audit |
| 2:50 | 3:00 | Break |
| 3:00 | 4:00 | Panel discission on Gen AI Use Cases War stories Where to get the most benefit |
| 4:00 | 4:10 | Break |
| 4:10 | 5:00 | Human Capital Update |
| Agenda: DAY 2 | ||
|---|---|---|
| 8:45 | 10:15 | Accounting for R&D and Clinical Trials R&D Funding Arrangements R&D Cost Classifications Other Intangible Assets SEC Comment Letter Trends |
| 10:15 | 10:30 | Break |
| 10:30 | 12:00 | Accounting for Financing Arrangements in Life Sciences Introduction Direct R&D Funding Arrangements NewCo R&D Funding Arrangements Royalty Monetizations |
| 12:00 | 12:45 | Lunch Break |
| 12:45 | 2:10 | Revenue Recognition for Collaboration & License Agreements Analyze key 606 considerations Understand disclosure expectations Practical approached for estimating and constraining variable consideration Review real-world examples |
| 2:10 | 2:20 | Break |
| 2:20 | 3:30 | Budgeting and Forecasting Best Practices Real life examples of successes and failures Forecast models Leverage different technology approaches |
| 3:30 | 3:40 | Break |
| 3:40 | 4:50 | SOX & Internal Controls Update Use of Gen AI Segment Reporting Control Considerations Risk Assessment refresh Deficiencies and severity assessment |
| Conference Series Speakers Include: |
|---|
| Eugene Bessacini PwC, Deals Director |
| Adam Barrow Riveron, Senior Director |
| Nick Sanfilippo Riveron, Director, Accounting Advisory & IPO |
| Glenn Snyder Riveron, Senior Director - Interim Management |
| Matt Norman Deloitte, Manager |
| Russ Higgins Connor Group, Partner |
| Marcus Lindner Ernst & Young, Partner |
| Margaret Smith Protiviti, Managing Director |
| Josh Aiello Orchestra BioMed, VP Finance & Corporate Controller |
| Salonee Hanspal Ernst & Young, Assurance Senior Manager |
| Gia Suber Ernst & Young, Senior - Technical Accounting Advisory Group |
| Kyle Straub PwC, Director |
| Aleks Zabreyko Connor Group, Managing Partner |
| Jeffrey Kummer Deloitte, Director of Tax Policy |
| Joshua Areola Ernst & Young, Assurance Senior Manager |
| Tim Geringer Ernst & Young, Senior Manager |
| James Bowie Ernst & Young, Managing Director, Technical Accounting Advisory Group |
| Joanne Lai Ernst & Young, Senior Manager |
| Tanner Schnitz Ernst & Young, Technical Accounting Manager |
| James Bowie Ernst & Young, Managing Director, Technical Accounting Advisory Group |
| Matt Lepley Connor Group, Partner |
| Christie Hutchinson Riveron, Managing Director, Technical Accounting & IPO |
| Nelson Chan Ernst & Young, Senior Manager |
| Abby Cohen Deloitte, Audit Senior Manager |